November 19, 2024

Triple Therapy Leads Lupus Nephritis Guidelines Update

ACR's 2024 lupus nephritis guidelines signal a shift to a triple therapy approach, moving away from traditional dual immunosuppressive treatment while proposing shorter steroid courses.

Conexiant

November 19, 2024

Can Fluid Restriction Stop MDMA Hyponatremia?

A 433% oxytocin increase—not vasopressin—correlated with MDMA-induced hyponatremia, with fluid restriction preventing all cases in a controlled setting.

Conexiant

November 18, 2024

Revised AF Guidelines for Dialysis Patients

"The components of the CHA2DS2-VASc score are so prevalent in HD patients with AF that most qualify for OAC if the guidelines are applied" - an observation from the study that challenges conventional risk assessment approaches for this high-risk population.

Conexiant

November 15, 2024

High BP at 40 Linked to 30-Year Stroke Risk

Women with systolic BP ≥140 mm Hg at age 40 face a striking 4x higher stroke risk over 30 years compared to those with optimal BP, new cohort study reveals.

Conexiant

November 13, 2024

Unique Genetic Risks Found for Aortic Stenosis

Conexiant

November 12, 2024

Lp(a) and LDL-C: Separate ASCVD Risk Factors

Conexiant

November 12, 2024

CKM Could Mean Decades Earlier CVD Risk

Conexiant

November 11, 2024

Morning BP Rise Linked to Heart Hypertrophy

A morning BP rise of over 10 mmHg independently predicts left ventricular hypertrophy—accounting for 36.2% of LVMI variability, even after adjusting for age and BMI.

Conexiant

November 11, 2024

Perirenal Fat Predicts Metabolic Syndrome Risk

A study revealed a strong association between perirenal fat thickness and metabolic syndrome risk, suggesting the potential of MRI-assessed perirenal fat thickness as a risk assessment component.

Conexiant